Intratumoral heterogeneity as a predictive biomarker in anti-PD-(L)1 therapies for non-small cell lung cancer
Paperity,
Letter to the Editor Open Access Published: 23 February 2021 Intratumoral heterogeneity as a predictive biomarker in anti-PD-(L)1…